- Home
- MPLX vs COR Comparison
MPLX vs COR Comparison
Compare MPLX & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MPLX | COR |
|---|---|---|
| Founded | 2012 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Other Pharmaceuticals |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.9B | 59.1B |
| IPO Year | 2012 | 2001 |
Fundamental Metrics
Financial Performance| Metric | MPLX | COR |
|---|---|---|
| Price | $57.83 | $313.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 14 |
| Target Price | $62.85 | ★ $369.25 |
| AVG Volume (30 Days) | ★ 1.2M | 1.1M |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | ★ 7.51% | 0.76% |
| EPS Growth | N/A | ★ 5.71 |
| EPS | N/A | ★ 15.21 |
| Revenue | $12,998,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $11.16 | $4.88 |
| Revenue Next Year | $7.22 | $4.73 |
| P/E Ratio | ★ $11.76 | $20.63 |
| Revenue Growth | 8.92 | ★ 9.31 |
| 52 Week Low | $47.94 | $244.82 |
| 52 Week High | $60.95 | $377.54 |
Technical Indicators
Market Signals| Indicator | MPLX | COR |
|---|---|---|
| Relative Strength Index (RSI) | 47.25 | 49.90 |
| Support Level | $57.49 | $299.49 |
| Resistance Level | $60.10 | $329.28 |
| Average True Range (ATR) | 1.18 | 7.67 |
| MACD | -0.15 | -0.18 |
| Stochastic Oscillator | 45.60 | 61.91 |
Price Performance
Historical ComparisonAbout MPLX MPLX LP
MPLX is a partnership that owns pipelines and gathering and processing assets with extensive holdings in the Appalachian and Permian regions. The asset base is made up of crude oil and refined products assets dropped down from Marathon Petroleum, its sponsor, and natural gas and natural gas liquids gathering and processing assets that were purchased or built.
About COR Cencora Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.